Tumor antigen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
WikiDoc Resources for Tumor antigen |
|
Articles |
|---|
|
Most recent articles on Tumor antigen Most cited articles on Tumor antigen |
|
Media |
|
Powerpoint slides on Tumor antigen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tumor antigen at Clinical Trials.gov Trial results on Tumor antigen Clinical Trials on Tumor antigen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tumor antigen NICE Guidance on Tumor antigen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tumor antigen Discussion groups on Tumor antigen Patient Handouts on Tumor antigen Directions to Hospitals Treating Tumor antigen Risk calculators and risk factors for Tumor antigen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tumor antigen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Tumor antigen is a substance produced in tumor cells that triggers an immune response in the host. Tumor antigens are useful in identifying tumor cells and are potential candidates for use in cancer therapy.
Mechanism of tumor antigenesis
Normal proteins in the body are not antigenic because of self-tolerance, a process in which self-reacting cytotoxic T lymphocytes (CTLs) and autoantibody-producing B lymphocytes are culled in the thymus. Thus any protein that is not exposed to the immune system triggers an immune response. This may include normal proteins that are well sequestered from the immune system, proteins that are normally produced in extremely small quantities, proteins that are normally produced only in certain stages of development, or proteins whose structure is modified due to mutation.
Types
Any protein produced in a a tumor cell that has an abnormal structure due to mutation can act as a tumor antigen. Such abnormal proteins are produced due to mutation of the concerned gene. Mutation of protooncogenes and tumor suppressors which lead to abnormal protein production are the cause of the tumor and thus such abnormal proteins are called tumor-specific antigens. Examples of tumor-specific antigens include the abnormal products of ras and p53 genes. In contrast, mutation of other genes unrelated to the tumor formation may lead to synthesis of abnormal proteins which are called tumor-associated antigens.
Proteins that are normally produced in very low quantities but whose production is dramatically increased in tumor cells, trigger an immune response. An example of such a protein is the enzyme tyrosinase, which is required for melanin production. Normally tyrosinase is produced in minute quantities but its levels are very much elevated in melanoma cells.
Oncofetal antigens are another important class of tumor antigens. Examples are alphafetoprotein (AFP) and carcinoembryonic antigen (CEA). These proteins are normally produced in the early stages of embryonic development and disappear by the time the immune system is fully developed. Thus self-tolerance does not develop against these antigens.
Abnormal proteins are also produced by cells infected with oncoviruses, eg. EBV and HPV. Cells infected by these viruses contain latent viral DNA which is transcribed and the resulting protein produces an immune response.
In addition to proteins, other substances like cell surface glycolipids and glycoproteins may also have an abnormal structure in tumor cells and could thus be targets of the immune system.
Importance of tumor antigens
Tumor antigens, because of their relative abundance in tumor cells are useful in identifying specific tumor cells. Certain tumors have certain tumor antigens in abundance.
| Tumor antigen | Tumor in which it is found | Remarks |
|---|---|---|
| Alphafetoprotein (AFP) | Germ cell tumors | |
| Carcinoembryonic antigen (CEA) | ||
| CA-125 | Ovarian cancer | |
| MUC-1 | breast cancer | |
| epithelial tumor antigen (ETA) | breast cancer | |
| Tyrosinase | malignant melanoma | normally present in minute quantities; greatly elevated levels in melanoma |
| Melanoma-associated antigen (MAGE) | malignant melanoma | Also normally present in the testis |
| abnormal products of ras, p53 | Various tumors |
Certain tumor antigens are thus used as tumor markers. More importantly, tumor antigens can be used in cancer therapy as tumor antigen vaccines. [1]
See also
References
- ↑ M Hareuveni, C Gautier, M Kieny, D Wreschner, P Chambon and R Lathe; Vaccination Against Tumor Cells Expressing Breast Cancer Epithelial Tumor Antigen; Proceedings of the National Academy of Sciences, Vol 87, 9498-9502, 1990.
- Kumar, Abbas, Fausto; Robbins and Cotran: Pathologic Basis of Disease; Elsevier, 7th ed.